Department of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
Department of Urology, Hopital de la Cavale Blanche, University of Brest, Brest, France.
Eur Urol Focus. 2020 Sep 15;6(5):1104-1110. doi: 10.1016/j.euf.2020.06.006. Epub 2020 Jun 15.
Determining whether members follow guidelines, including guidelines prepared to help direct practice management during the coronavirus disease 2019 (COVID-19) pandemic, is an important goal for medical associations.
To determine whether practice of urologists is in line with guidelines for the management of common urological conditions during the COVID-19 pandemic produced by leading (inter)national urological associations.
DESIGN, SETTING, AND PARTICIPANTS: Self-selected urologists completed a voluntary survey available online from March 27 to April 11, 2020 and distributed globally by the Société Internationale d'Urologie.
Responses to two survey questions on the (1) management of 14 common urological procedures and (2) priority scoring of 10 common urological procedures were evaluated by practice setting and geographical region using chi-square and one-way analysis of variance analyses, respectively.
There were 2494 respondents from 76 countries. Oncological conditions were prioritised over benign conditions, and benign conditions were deferred when feasible and safe. Oncological conditions with the greatest malignant potential were prioritised over less aggressive cancers. Respondents from Europe were least likely to postpone and most likely to prioritise conditions identified by guidelines as being of the highest priority. Respondents' priority scoring of urological procedures closely matched the priorities assigned by guidelines. The main limitation of this study is that respondents were self-selected, and access to the survey was limited by language and technology barriers.
Prioritisation and management of urological procedures during the COVID-19 pandemic are in line with current guidelines. The greatest agreement was reported in Europe. Observed differences may be related to limited resources in some settings.
When deciding how best to treat patients during the coronavirus disease 2019 (COVID-19) pandemic, urologists are taking into account both expert recommendations and the availability of important local resources.
确定成员是否遵循指南,包括为指导 2019 年冠状病毒病(COVID-19)大流行期间的实践管理而制定的指南,是医学协会的一个重要目标。
确定领先的(国际)泌尿科协会制定的 COVID-19 大流行期间常见泌尿科疾病管理指南在泌尿科医生实践中的应用情况。
设计、地点和参与者:自我选择的泌尿科医生于 2020 年 3 月 27 日至 4 月 11 日通过 Société Internationale d'Urologie 在线完成了一项自愿调查,并在全球范围内进行了分发。
根据实践环境和地理区域,使用卡方检验和单向方差分析分别评估了对两个调查问题的回答,问题 1 为 14 种常见泌尿科手术的管理,问题 2 为 10 种常见泌尿科手术的优先级评分。
来自 76 个国家的 2494 名受访者参与了调查。肿瘤性疾病优先于良性疾病,在可行和安全的情况下,良性疾病可被推迟。恶性潜力最大的肿瘤性疾病优先于侵袭性较小的癌症。来自欧洲的受访者最不可能推迟治疗,最有可能优先考虑被指南确定为优先级最高的疾病。受访者对泌尿科手术的优先评分与指南分配的优先级密切匹配。本研究的主要局限性在于受访者是自我选择的,并且语言和技术障碍限制了对调查的访问。
COVID-19 大流行期间泌尿科手术的优先排序和管理与当前指南一致。在欧洲观察到的一致性最高。观察到的差异可能与某些环境中资源有限有关。
在决定如何在 2019 年冠状病毒病(COVID-19)大流行期间为患者提供最佳治疗时,泌尿科医生不仅考虑了专家建议,还考虑了当地重要资源的可用性。